Literature DB >> 18699836

Sneddon-Wilkinson disease treated with etanercept: report of two cases.

D R Berk1, M A Hurt, C Mann, D Sheinbein.   

Abstract

Sneddon-Wilkinson disease (SWD), also known as subcorneal pustular dermatosis, is a rare, chronic eruption that is often difficult to treat, particularly in patients who do not respond to or cannot tolerate dapsone. Few case reports exist of patients with SWD treated with antitumour necrosis factor-alpha therapy. We report two patients with SWD refractory to numerous treatments, who responded to etanercept (in combination with low-dose acitretin in one case).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18699836     DOI: 10.1111/j.1365-2230.2008.02905.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  5 in total

1.  Subcorneal pustular dermatosis and episcleritis associated with poorly controlled ulcerative colitis.

Authors:  Jeffrey J Wargo; Megan Adams; Julian Trevino
Journal:  BMJ Case Rep       Date:  2017-01-30

Review 2.  Interruption of Sneddon-Wilkinson Subcorneal Pustulation with Infliximab.

Authors:  Lorenz Kretschmer; Julia-Tatjana Maul; Thomas Hofer; Alexander A Navarini
Journal:  Case Rep Dermatol       Date:  2017-04-27

Review 3.  Subcorneal pustular dermatosis: Comprehensive review and report of a case presenting during pregnancy

Authors:  Shashank Bhargava; Ujjwal Kumar; George Kroumpouzos
Journal:  Int J Womens Dermatol       Date:  2020-02-20

4.  Sneddon-Wilkinson Disease and Monoclonal Gammopathy of Undetermined Significance in the Elderly: Case Report.

Authors:  Gabriele Ceccarelli; Elisa Molinelli; Anna Campanati; Gaia Goteri; Annamaria Offidani
Journal:  Case Rep Dermatol       Date:  2019-07-10

Review 5.  Biologics in dermatology: an integrated review.

Authors:  Virendra N Sehgal; Deepika Pandhi; Ananta Khurana
Journal:  Indian J Dermatol       Date:  2014-09       Impact factor: 1.494

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.